Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121635) titled 'Study on the mechanism of functional cure of High-dose hepatitis B vaccine combined with Long-acting interferon in patients with chronic hepatitis B and low HBsAg' on April 1.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Xixi Hospital of Hangzhou
Condition:
Chronic viral hepatitis B
Intervention:
Group B :polyethylene glycol interferon a-2b
Group C :60 µg hepatitis B vaccine
Group A :Pegylated interferon a-2b and 60ug hepatitis B vaccine group
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-01
Target Sample Size: Group B ...